Crown Bioscience Inc., of Santa Clara, Calif., said it expanded its cardiovascular and metabolic disease (CVMD) research in New Iberia, Louisiana by investing in facilities at the University of Louisiana at Lafayette's New Iberia Research Center, the largest national primate research center in the U.S.